Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: Study protocol for a multi-center randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Chen, I Chih ^a   Lee, Cheng Han ^b   Chao, Ting Hsing ^b   Tseng, Wei Kung ^c   Lin, Tsung Hsien ^d   Chung, Wen Jung ^e   Li, Jen Kwan ^f   Huang, Hsuan Li ^g   Liu, Ping Yen ^b   Chao, Ting Kuang ^h,i   Chu, Chuin Yuan ^d   Lin, Chih Chan ^b   Hsu, Po Chao ^d   Lee, Wen Huang ^b   Lee, Po Tseng ^b   Li, Yi Heng ^b   Tseng, Shih Ya ^b   Tsai, Liang Miin ^b   Hwang, Juey Jen ^f  

^a TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c Department of Internal Medicine   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^h FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY CATHETERIZATION; ARTERY DISEASE; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY CATHETERIZATION; EXERCISE TEST; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LOW EXTREMITY ARTERY DISEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT DECISION MAKING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TAIWAN; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HEART CATHETERIZATION; LOWER LIMB; METHODOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VASCULARIZATION;

ANGIOPLASTY, BALLOON; CARDIAC CATHETERIZATION; CLINICAL PROTOCOLS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EXERCISE TEST; HUMANS; LOWER EXTREMITY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84978730688     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1237-0     Document Type: Article

References (29)

1. Duran NE, Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. Mortality over a period of 10years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
2. Duran NE, Duran I, Gürel E, Gündüz S, Göl G, Biteker M, et al. Coronary artery disease in patients with peripheral artery disease. Heart Lung. 2010;39:116-20.
3. Rohani M, Jogestrand T, Ekberg M, van der Linden J, Källner G, Jussila R, et al. Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis. 2005;179:311-6.
4. Lekakis JP, Papamichael C, Papaioannou TG, Stamatelopoulos KS, Cimponeriu A, Protogerou AD, et al. Intima-media thickness score from carotid and femoral arteries predicts the extent of coronary artery disease: intima-media thickness and CAD. Int J Cardiovasc Imaging. 2005;21:495-501.
5. Sukhija R, Yalamanchili K, Aronow WS, et al. Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol. 2003;92:304-5.
6. Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. 2009;54:989-96.
7. Hussein AA, Uno K, Wolski K, Kapadia S, Schoenhagen P, Tuzcu EM, et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol. 2011;57:1220-5.
8. Dávila-Román VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Pérez JE, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol. 1993;21:957-63.
9. Wolf YG, Landersberg G, Mosseri M, Schechter D, Anner H, Weissman C, et al. Preoperative dipyridamole-thallium scanning, selective coronary revascularization and long-term survival in patients with critical lower limb ischemia. J Cardiovasc Surg (Torino). 2001;42:89-95.
10. Landesberg G, Mosseri M, Wolf YG, Bocher M, Basevitch A, Rudis E, et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation. 2003;108:177-83.
11. Landesberg G, Berlatzky Y, Bocher M, Alcalai R, Anner H, Ganon-Rozental T, et al. A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgery. Eur Heart J. 2007;28:533-9.
12. Massie MT, Rohrer MJ, Leppo JA, Cutler BS, et al. Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans? J Vasc Surg. 1997;25:975-82.
13. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-804.
14. Schouten O, van Kuijk JP, Flu WJ, Winkel TA, Welten GM, Boersma E, et al. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study). Am J Cardiol. 2009;103:897-901.
15. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol. 2009;54:e13-118.
16. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-906.
17. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:2020-45.
18. Chen IC, Chao TH, Fang CC, Wu IH, Yu CL, Lam CY. Prognostic determinants of intermediate-term outcome in patients with peripheral artery disease undergoing percutaneous transluminal angioplasty in southern Taiwan---a single operator's experience. Acta Cardiol Sin. 2013;29 Suppl:58.
19. Abularrage CJ, Conrad MF, Hackney LA, Paruchuri V, Crawford RS, Kwolek CJ, et al. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg. 2010;52:314-22.e1-4.
20. Chen IC, Yu CC, Wu YH, Chao TH. Elevated neutrophil-to-lymphocyte ratio predicts intermediate-term outcomes in patients who have advanced chronic kidney disease with peripheral artery disease receiving percutaneous transluminal angioplasty. Acta Cardiol Sin. (in press)
21. Huang HL, Chou HH, Wu TY, Chang SH, Tsai YJ, Hung SS, et al. Endovascular intervention in Taiwanese patients with critical limb ischemia: patient outcomes in 333 consecutive limb procedures with a 3-year follow-up. J Formos Med Assoc. 2014;113:688-95.
22. Parmar JH, Aslam M, Standfield NJ, et al. Percutaneous transluminal angioplasty of lower limb arteries causes a systemic inflammatory response. Ann Vasc Surg. 2009;23:569-76.
23. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ, et al. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26:115-21.
24. Yassin MM, Barros D'Sa AA, Parks G, Abdulkadir AS, Halliday I, Rowlands BJ, et al. Mortality following lower limb ischemia-reperfusion: a systemic inflammatory response? World J Surg. 1996;20:961-6.
25. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
26. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295-309.
27. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346, e7586.
28. Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355-60.
29. Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, et al. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 2014;349:g6427.